Qure.ai is an Artificial Intelligence (AI) solutions provider for medical imaging diagnostics assisting clinicians in accurately and quickly interpreting time-bound critical scans. Qure’s solutions are targeted to support radiology workflows with triage and faster treatment decision-making, enabling better patient outcomes. Qure’s flagship products include: 
 

·         qER (Head CT interpretation & triage). 

·         qXR (CXR interpretation). 

·         qCT (chest CT interpretation). 

·         qMSK (MSK X-ray interpretation). 

 
Qure.ai is one of the most reputed companies in AI medical imaging, with deployments in over 70+ countries, including the UK’s NHS, impacting 12+ million patient lives globally.  

 

The UK’s healthcare system is overwhelmed, with increasingly crowded departments and overburdened staff. As a result, patients queuing for admissions have become a common sight in A&E departments in many NHS Trusts.  

 

qER is an AI algorithm developed to accurately interpret multiple abnormalities on a non-contrast head CT scan and deliver reports to clinicians in under < 3 minutes. When treating patients in A&E, speed and accuracy are pivotal. qER is specifically designed to address some of the problems faced by Emergency Medicine consultants by reducing the time to diagnosis and speeding up the treatment decision-making process.  

 

qER empowers Emergency Medicine consultants to make faster treatment decisions for suspected stroke cases, whether to admit/ transfer/ discharge the patients, and helps them to manage patient inflows & outflows better. It also acts as a second set of eyes to avoid missing any subtle abnormalities on a head CT, especially in the after-hours workflows.  

 

qER is an FDA-cleared and CE class IIb-approved product and the first-ever medical AI algorithm to be featured in the Lancet. qER has also won an NHSxAI award and is currently deployed in multiple NHS trusts across the UK.